Request Deal Involvement

Jeito, Ridgeback, SV Health and Fidelity led a $156m Series B funding round in Quell Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

MEDiSTRAVA Consulting

pr advisors

MEDiSTRAVA Consulting

Precision AQ

pr advisors

Precision AQ

or

Principals

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

QUELL THERAPEUTICS

target

QUELL THERAPEUTICS

JEITO CAPITAL

bidder

JEITO CAPITAL

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

TEKLA CAPITAL MANAGEMENT LLC

bidder

TEKLA CAPITAL MANAGEMENT LLC

SV HEALTH INVESTORS

bidder

SV HEALTH INVESTORS

POINT72 VENTURES

bidder

POINT72 VENTURES

RIDGEBACK CAPITAL INVESTMENTS

bidder

RIDGEBACK CAPITAL INVESTMENTS

BRITISH PATIENT CAPITAL

bidder

BRITISH PATIENT CAPITAL

MONASHEE INVESTMENT MANAGEMENT

bidder

MONASHEE INVESTMENT MANAGEMENT

SYNCONA LTD

bidder

SYNCONA LTD

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Jeito, Ridgeback, SV Health and Fidelity led a $156m Series B funding round in Quell Therapeutics.